InvestorsHub Logo
Followers 16
Posts 1063
Boards Moderated 0
Alias Born 09/01/2019

Re: None

Wednesday, 11/25/2020 12:27:10 PM

Wednesday, November 25, 2020 12:27:10 PM

Post# of 44690

Great news that RLF-100 is working in the EAP and CT patients. Should provide good interest from investors at RLF.SW and RLFTF.

RLFTF/RLF.SW, thru money raises (dilution) has funded the current Clinical Trials, the R + D and will raise money for Inhaled RLF Trial progressing to enrollments. RLFTF is funding production of VIPs.

What benefits do RLFTF/RLF.SW shareholders derive from NRX?
How does NRX claim RLF-100 besides as a distribution / logistic partner? Will NRX raise it's own money to fulfill the IPO? The NRX IPO PR involves RLF-100.

{(NRX-private) +- (RLFTF/RLF.SW-3B OS)} + RLF-100 / Dr. JJ*NRX + Biggie Pharma + RLF-100 +- (RLFTF/RLF.Sw)} = "IPO"?

But, can anyone explain or guess how this all goes together and RLFTF/RLF.SW how shareholders will participate or be compensated? Seems to me like we pay, they gain, DrJJ wins twice +.....